May 27 2010 - No Comments
MMC and Novo Nordisk’s Victoza, for the treatment of T2D, Continue to Make News
There are no comments yet, be the first.
Name (required)
Email (required)
Website
Allowed tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
Notify me of followup comments via e-mail
